Coronavirus (COVID-19) Update
AmerisourceBergen and our global businesses are highly engaged during the ongoing spread of the novel COVID-19 “Coronavirus."
February 20, 2018
US Bioservices now dispenses ERLEADA
The U.S. Food and Drug Administration has approved ERLEADA (apalutamide) for non-metastatic castration-resistant prostate cancer.